NCT03321656: An ongoing trial by Roberto Gedaly
This trial is ongoing. It must report results 1 year, 5 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT03321656 |
|---|---|
| Title | Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | March 28, 2019 |
| Completion date | March 31, 2026 |
| Required reporting date | March 31, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Sept. 16, 2025 |
| Days late | None |